CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 706 enrolled
Drug / intervention
Immediate multivessel PCI +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01927549
NCT01927549Phase 4Completed

Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

University of Luebeck·interventional·Posted Aug 22, 2013·Updated Nov 9, 2017

In Brief

A Phase 4 clinical trial evaluating Immediate multivessel PCI and Culprit Lesion only PCI for Cardiogenic Shock and 2 related conditions. Completed, enrolled 706 participants across 3 sites.

Detailed Summary

The study compares the therapies of instant multivessel balloon angioplasty plus stent implantation or the balloon angioplasty plus stent implantation of the infarct artery alone with any possible graduated later treatment of the other vessels in patients with acute myocardial infarction with cardioganic shock. The main study hypothesis is to explore if culprit vessel only PCI with potentially subsequent staged revascularization in comparison to immediate multivessel revascularization by PCI in patients with cardiogenic shock complicating acute myocardial infarction reduces the incidence of 30- day mortality and/or severe renal failure requiring renal replacement therapy.

Study Details

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 22, 2013
Enrollment StartApr 1, 2013
Primary CompletionJul 1, 2017
Study CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.9 years ago

Interventions

Immediate multivessel PCIprocedure

Culprit Lesion only PCIprocedure